Concepedia

Jason J. Klein

JJ

6

Publications

1.2K

Citations

6

H-Index

2005

Active since

Affiliations

Arrowhead Pharmaceuticals (United States)(Current)

Mirus Bio (United States)

University of Wisconsin–Madison

Jason J. Klein is an author at Arrowhead Pharmaceuticals (United States) specializing in medicine, biomolecular engineering, and gene delivery.

Top concepts

Publications per year

2005–2015

6

Publications

6

Dynamic PolyConjugates for targeted <i>in vivo</i> delivery of siRNA to hepatocytes

David B. Rozema, David L. Lewis, Darren H. Wakefield et al. · Proceedings of the National Academy of Sciences · 2007 · 679 citations · Full text

, , +17

Hepatocyte-targeted RNAi Therapeutics for the Treatment of Chronic Hepatitis B Virus Infection

Christine I. Wooddell, David B. Rozema, Matthias John et al. · Molecular Therapy · 2013 · 289 citations · Full text

Co-Injection of a Targeted, Reversibly Masked Endosomolytic Polymer Dramatically Improves the Efficacy of Cholesterol-Conjugated Small Interfering RNAs <i>In Vivo</i>

So C. Wong, Jason J. Klein, Holly Hamilton et al. · Nucleic Acid Therapeutics · 2012 · 100 citations · Full text

Membrane Activity and Transfection Ability of Amphipathic Polycations as a Function of Alkyl Group Size

Darren H. Wakefield, Jason J. Klein, Jon A. Wolff et al. · Bioconjugate Chemistry · 2005 · 47 citations

, , +18

Protease-triggered siRNA delivery vehicles

David B. Rozema, Andrei V. Blokhin, Darren H. Wakefield et al. · Journal of Controlled Release · 2015 · 40 citations · Full text

Rows per page

1–5 of 6